However, the evidence is weak overall. The 2015 study was published in the Journal of Stem Cell Research & Therapy, an open-access outlet sometimes flagged in discussions of predatory journals that may lack rigorous peer review. Key authors, including Christian Drapeau (founder of supplement company STEMREGEN and former executive at Stemtech, which funded the research), have clear financial ties to products marketing these stem cell claims, raising bias concerns. No independent replications or larger-scale studies appear in the scientific literature to confirm the findings. Health authorities like the FDA warn against unproven stem cell supplements in general, noting risks such as false claims, lack of safety data, and potential harm from unregulated products. While the plant shows some preliminary activity in that one trial, it’s far from established as “really effective” for stem cell release based on robust, unbiased science—more like promotional hype than proven therapy. If considering it for health reasons, consult a doctor, as oral supplements claiming stem cell benefits often fall into unregulated territory.